For many women, the cause of infertility is the result of after effects from breast cancer treatment, mainly chemotherapy. There have been options for preserving a woman’s fertility, such as freezing eggs, ovarian tissue or embryos for use at a later time.
There’s good news coming from research study that provides another option for women going through breast cancer treatment.
The study used a new intervention, a hormone-blocking drug called Goserelin. This new drug shuts down ovarian function during chemotherapy and protects the ovaries from chemotherapy toxicity.
Women who received the intervention were less likely to experience ovarian failure two years following the study, increasing the likelihood of pregnancy.
And, surprisingly, the results found other added benefits – fewer recurrences of breast cancer and better overall survival rate!
Goserelin is used for other gynecologic conditions to shut down ovarian function as well as testicular function for advanced breast and prostate cancers.
For women diagnosed with breast cancer, be sure and talk to your oncologist or a fertility specialist about how to preserve fertility if they wish to start a family in the future.